{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:38:00Z","timestamp":1773848280859,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vaccine.2025.128113","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T16:05:39Z","timestamp":1765641939000},"page":"128113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunogenicity and safety of inactivated quadrivalent influenza vaccines in children aged 6\u201335\u00a0months: A multi-center, randomized, double-blind, active-controlled clinical trial"],"prefix":"10.1016","volume":"71","author":[{"given":"Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingya","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taotao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeqing","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.vaccine.2025.128113_bb0005","first-page":"185","article-title":"Vaccines against influenza: WHO position paper \u2013 may 2022","volume":"97","author":"Organization, W.H","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128113_bb0010","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1016\/S2214-109X(19)30545-5","article-title":"Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128113_bb0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/infdis\/134.6.633","article-title":"Summary of clinical trials of influenza vaccines-II","volume":"134","author":"Wright","year":"1976","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128113_bb0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/infdis\/136.5.623","article-title":"A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children","volume":"136","author":"Gross","year":"1977","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128113_bb0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S2352-4642(18)30062-2","article-title":"Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons","volume":"2","author":"Claeys","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"13","key":"10.1016\/j.vaccine.2025.128113_bb0030","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.vaccine.2018.11.074","article-title":"Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35\u00a0months: a multi-season randomised placebo-controlled trial in the northern and southern hemispheres","volume":"37","author":"Pepin","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128113_bb0035","first-page":"9","article-title":"Time to change dosing of inactivated Quadrivalent influenza vaccine in young children: evidence from a phase III, randomized, controlled trial","volume":"6","author":"Jain","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128113_bb0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/INF.0000000000002227","article-title":"Safety and immunogenicity of a full-dose, Split-virion, inactivated, Quadrivalent influenza vaccine in healthy children 6-35 months of age: a randomized controlled clinical trial","volume":"38","author":"Robertson","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128113_bb0045","doi-asserted-by":"crossref","first-page":"2132798","DOI":"10.1080\/21645515.2022.2132798","article-title":"Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: results from two studies","volume":"18","author":"Liu","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128113_bb0050","doi-asserted-by":"crossref","first-page":"2425149","DOI":"10.1080\/21645515.2024.2425149","article-title":"Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6-35 months of age in China: a randomized, double-blind, clinical trial","volume":"20","author":"Wang","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"37","key":"10.1016\/j.vaccine.2025.128113_bb0055","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1016\/j.vaccine.2020.06.071","article-title":"Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III study in healthy population aged \u22653 years","volume":"38","author":"Chu","year":"2020","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128113_bb0065","article-title":"Febrile seizures in children: a review","volume":"14","author":"Tiwari","year":"2022","journal-title":"Cureus"},{"issue":"18","key":"10.1016\/j.vaccine.2025.128113_bb0070","first-page":"1379","article-title":"Chinese Expert Consensus on the Diagnosis, Treatment, and Management of Febrile Seizures (2017 Practical Edition)","volume":"32","author":"Neurology Group of the Chinese Medical Association Science Branch","year":"2017","journal-title":"Chinese Journal of Applied Clin Pediatr"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128113_bb0075","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1080\/21645515.2020.1721994","article-title":"Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6-35 months in China","volume":"16","author":"Hu","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128113_bb0085","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.idnow.2021.05.004","article-title":"Pediatric infectious disease group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?","volume":"51","author":"Cohen","year":"2021","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.vaccine.2025.128113_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107231","article-title":"Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study","volume":"148","author":"Lastrucci","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"50","key":"10.1016\/j.vaccine.2025.128113_bb0095","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1016\/j.vaccine.2017.10.074","article-title":"Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh","volume":"35","author":"Rolfes","year":"2017","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2025.128113_bb0100","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1010331","article-title":"Oil-in-water emulsion adjuvant with influenza vaccine in young children","volume":"365","author":"Vesikari","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:59:01Z","timestamp":1773827941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":18,"alternative-id":["S0264410X25014112"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128113","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of inactivated quadrivalent influenza vaccines in children aged 6\u201335\u00a0months: A multi-center, randomized, double-blind, active-controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128113"}}